• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/20

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

20 Cards in this Set

  • Front
  • Back
weak acid in acid medium is?
can it pass?
non-ionized
yes
weak base in acid medium is?
can it pass?
ionized
no
pharmaceutical phase
swallow, disintegration, dissolution
whats special about sublingual
what the drug has to be
without metabolism via liver
lipophilic and uncharged to be absorbed in oral mucosa
albumin binds
lipophilic and anionic (weak acid)
Alpha 1 acid glycoprotein binds
cationic, and very hydrophilic drugs
result of malnutrtion in
1. albumin
2. alpha 1 ACID GLYCORPROTEIN
1. less albumin, higher free conc. of drug
2. more alpha 1, lower free drug conc.
Volume of Distribution formula
Vd=D/C
Total amount of drug in body=D
plasma conc. of drug=C
Vd of small VD?
intermediate VD?
0.057 L/kg
0.2L/KG
phase 1 metabolism modification
increase polarity by -OH -NH2
Redox and hydrolysis
more/less active or equal active
P450
phase 2 metabolism modification
increase polarity by conjugation
glucuronic, sulfate, acetate, aa.
less active
UGTs
UDP-glucuronosynltransferase

transfer?
modification?
glucuronic acid
more polar
Sulfotransferases (SULTs)
sulfate to hydroxyl
more polar
Glutathione S Transferases (GSTs)
glutathion, anti-oxidant,
less toxic
N-acetyltransferases (NATs)
acetyle group,
genetic polymorphism
Thiopurine Methyltransferase (TPMT)
methyl, from S-adenosylmethionine
genetic polymorphism, protective
CYP2C9 SNPs
metabolize anticoagulant drug warfarin
require lower dose of warfarin, can cause bleeding
CYP2D6
metabolize codeine to morphine (morphine>codeine)
4 genotypes
ultra rapid:increase, with multiple copy of gene
extensive: normal
intermediate: reduced
poor:none
UGT1A1 SNPs
decrease activity
an anticancer compound
-increase risk of diarrhea and bone marrow suppression
NAT2 SNPs
acetylate drug "isoniazid used to treat Tb" and caffeine and cancer causing chemicals
patieient slow/rapid acetylator
slow acetylator: more isonizid toxicisty and more cancer